Literature DB >> 5866726

A kinetic study of the elimination of 3-methylsalicylic acid and its acetyl derivative in man.

A J Cummings, B K Martin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5866726      PMCID: PMC1510752          DOI: 10.1111/j.1476-5381.1965.tb02065.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  5 in total

1.  DRUG ELIMINATION BY SIMULTANEOUS FIRST-ORDER AND ZERO-ORDER PROCESSES.

Authors:  A J CUMMINGS; B K MARTIN; G S PARK
Journal:  Nature       Date:  1964-05-23       Impact factor: 49.962

2.  A KINETIC STUDY OF THE ELIMINATION OF SALICYLATE IN MAN.

Authors:  C BEDFORD; A J CUMMINGS; B K MARTIN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

3.  The binding by bovine plasma and plasma fractions of salicylic acid and some of its 3-alkyl analogues.

Authors:  W L STAFFORD
Journal:  Biochem Pharmacol       Date:  1962-08       Impact factor: 5.858

4.  Ortho-cresotinate and diabetes mellitus.

Authors:  T D LIGHTBODY; J REID
Journal:  Br Med J       Date:  1960-06-04

5.  [De-acetalization and elimination in vivo of some salicylate derivatives: acetylsalicylic acid (aspirin) and acetylorthocresotic acid (cresopirin); calculation of hemicresis time and protorrhea].

Authors:  P BASTIDE
Journal:  Ann Biol Clin (Paris)       Date:  1954 Oct-Dec       Impact factor: 0.459

  5 in total
  3 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  The effect of 3-methyl salicylic (O-cresotinic) acid on plasma insulin and glucose tolerance in diabetic and non-diabetic subjects.

Authors:  D E Hyams; A N Howard; I E Evans; S H Davison
Journal:  Diabetologia       Date:  1971-04       Impact factor: 10.122

3.  Bio-distribution in rats of some salicylates with low gastric ulcerogenicity.

Authors:  K D Rainsford; A Schweitzer; P Green; M W Whitehouse; K Brune
Journal:  Agents Actions       Date:  1980-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.